MAM
PLRX icon

Monaco Asset Management’s Pliant Therapeutics PLRX Stock Holding History

Monaco Asset Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Hold
1,938,747
– – 0.18% 33
2026
Q1 		$2.44M Hold
1,938,747
– – 0.45% 37
2025
Q4 		$2.37M Buy
1,938,747
+1,116,054
+136% +$1.68M 0.41% 47
2025
Q3 		$1.22M Buy
822,693
+120,300
+17% +$184K 0.07% 60
2025
Q2 		$815K Buy
+702,393
New +$992K 0.14% 73

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Monaco Asset Management's PLRX Position: Q2 2026 in Review

Monaco Asset Management held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 1,938,747 shares worth $2.21M. The position accounts for 0.18% of the portfolio, ranked #33.

Monaco Asset Management first reported a position in PLRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.44M in Q1 2026. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Monaco Asset Management held 1,938,747 shares of Pliant Therapeutics worth $2.21M as of Q2 2026.
  • Monaco Asset Management left its Pliant Therapeutics share count unchanged in Q2 2026.
  • Pliant Therapeutics made up 0.18% of Monaco Asset Management's portfolio in Q2 2026, its #33 holding.
  • Monaco Asset Management first reported a position in Pliant Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Monaco Asset Management's Pliant Therapeutics position peaked at $2.44M in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.